Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status:
Completed
Trial end date:
2012-06-18
Target enrollment:
Participant gender:
Summary
The primary objective is to demonstrate the safety and tolerability of COV795 with up to 35
days use as evaluated by physical exam, vital signs, pulse oximetry, clinical laboratory
tests, and other adverse events (AEs).